pntd.0009734.s004.tif (84.32 kB)

Patients follow-up: intralesional route.

figure

posted on 2021-09-23, 17:45 authored by Carla Oliveira-Ribeiro, Maria Inês Fernandes Pimentel, Liliane de Fátima Antonio Oliveira, Érica de Camargo Ferreira e Vasconcellos, Fatima Conceição-Silva, Armando de Oliveira Schubach, Aline Fagundes, Cintia Xavier de Mello, Eliame Mouta-Confort, Luciana de Freitas Campos Miranda, Claudia Maria Valete-Rosalino, Ana Cristina da Costa Martins, Raquel de Vasconcellos Carvalhaes de Oliveira, Leonardo Pereira Quintella, Marcelo Rosandiski Lyra

IL- intralesional route; AR- alternative regimen; SR- standard regimen.

(TIF)

History

Usage metrics

Read the peer-reviewed publication

An old drug and different ways to treat cutaneous leishmaniasis: Intralesional and intramuscular meglumine antimoniate in a reference center, Rio de Janeiro, Brazil

PLOS Neglected Tropical Diseases

Categories

Keywords

rio de janeiro remains challenging since good options especially first therapy option xlink "> sr xlink "> treatment brazil </ p sr ): intramuscular xlink "> ar patients initially treated 5 mg sb although sr treatment intramuscular meglumine antimoniate il showed efficacy evolution time longer drugs currently used treat cutaneous leishmaniasis 3 %, 84 5 %, 2 9 %; p 6 %; p 4 %, respectively ar ): im meglumine antimoniate cutaneous leishmaniasis sr group 9 %,il ):treatment interruption respectively ).il treatment 2 months il patients cutaneous lesions 592 patients underwent physical thus contributing subcutaneous injections statistical analysis standardized scale standard regimen square tests safe strategy rescue scheme reference center quite toxic pearson chi outcome measures old drug main objective lethality unrelated laboratory examination historical cohort graded using frequently led fisher exact different ways complete healing adverse events abandonment rate 90 ).6 %),50 years 30 days 20 days 02 ).

Licence

Exports